Top Page
|
English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Thursday, April 18, 2024
Press Releases for Tuesday, October 19, 2021
Ev Dynamics Delivers Over 70 Electric Minibuses to the Philippines
19:10 HKT/SGT
Woven Capital Invests in UP.Partners' New Venture Capital Fund Dedicated to Powering the Future of Mobility Through Emerging Technology
16:04 HKT/SGT
Myanmar Government to Re-Open Schools, Revive Economy and Support Currency to Overcome 'Triple Crisis Situations' of Pandemic, Economic Slowdown and Issues of National Stability
15:30 HKT/SGT
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
15:00 HKT/SGT
Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines Studies - OCT Webinar
15:00 HKT/SGT
Mitsubishi Heavy Industries Engineering Successfully Completes Testing of New "KS-21" Solvent for CO2 Capture
14:37 HKT/SGT
Hitachi, Tohoku University and Kyoto University Become World's First to Establish Technology for Highly Efficient, High-quality Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT
13:03 HKT/SGT
Mitsubishi Power Receives Order of Two Gas Turbines for the Hunter Power Project in Australia
12:19 HKT/SGT
WARC, TikTok and Publicis Groupe release "From Discovery to Purchase: The Role of Community Commerce" a new study revealing the potential of creator-driven marketing for brand growth
10:00 HKT/SGT
Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment
09:28 HKT/SGT
CSPro Chain Announces Its CSPRO Token Presale
09:00 HKT/SGT
Entry into 3-Year Lease for an Industrial Property in Singapore to Commence Production of Lab-Grown Diamonds
06:32 HKT/SGT
ACN Search:
RSS
News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Privacy Policy
|
Terms of Use
|
RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575
Connect With us: